Holen Sie sich die Stockscreener-App
0.2871
7.33%
0.0196
IGC Pharma Inc Aktie (IGC) Neueste Nachrichten
IGC|IGC Pharma Inc|Price:0.266|Chg%:+0.002 - TradingKey
IGC Pharma Inc (IGC) Cash Flow - TradingKey
IGC Pharma Inc (IGC) Balance Sheet - TradingKey
IGC Pharma Inc (IGC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IGC Pharma Inc (IGC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IGC Pharma Inc (IGC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IGC Pharma, Inc. Revenue Breakdown – SWB:IGS1 - TradingView
IGC Pharma, Inc. Revenue Breakdown – LS:A1T87A - TradingView
IGC Pharma Inc (IGC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IGC Pharma Inc (IGC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IGC Pharma Inc (IGS1.DU) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Enterprise value to revenue forward of IGC Pharma, Inc. – SWB:IGS1 - TradingView
Price to earnings forward of IGC Pharma, Inc. – SWB:IGS1 - TradingView
IGC Pharma Q1 2026 Earnings: Narrower Loss Meets Improved Efficiency Amid Market SlumpEPS Surprise History - dars.gov.et
IGC Pharma (NYSE: IGC) maps $3B–$10B Alzheimer’s agitation market in new deck - Stock Titan
IGC Pharma furnishes updated investor presentation, details CALMA Phase 2 progress and interim data - TradingView
The 6 Best Stocks Under 50 Cents To Buy This Year - The Stock Dork
IGC Pharma (NYSE: IGC) Showcasing 7 AI Breakthroughs Advancing Alzheimer’s Drug Discovery at AAIC 2026 - Barchart.com
IGC Pharma Showcases AI Portfolio at AAIC 2026 - ACCESS Newswire
Enterprise value to revenue forward of IGC Pharma, Inc. – FWB:IGS1 - TradingView
Price to earnings forward of IGC Pharma, Inc. – FWB:IGS1 - TradingView
IGC Pharma (NYSE: IGC) CEO Discusses AI, Alzheimer’s Drug Development and Key 2026 Catalysts on The Street Podcast - Nonstop Local News
IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow - Black Hills Pioneer
IGC Pharma puts AI tools on display for Alzheimer’s research in London - Stock Titan
IGC Pharma (NYSE: IGC) CEO Discusses AI, Alzheimer's Drug - openPR.com
FinancialContentIGC Pharma (NYSE: IGC) CEO Discusses AI, Alzheimer’s Drug Development and Key 2026 Catalysts on The Street Podcast - FinancialContent
IGC Pharma (NYSE: IGC) CEO discusses AI, Alzheimer's drug development and key 2026 catalysts on The Street podcast - MSN
IGC Pharma (IGC) Declines Near Key Support as Selling Pressure PersistsRetail Volume - dars.gov.et
IGC: CEO and CFO Acquire 4.27 Million Shares in Company Stock - GuruFocus
IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company - BioSpace
IGC Pharma CEO, finance chief buy $1.15M of common stock - MSN
IGC Pharma Executives Convert Debt Into Equity Shares - TipRanks
Executives convert $1,154,210 owed into IGC (NYSE: IGC) stock - Stock Titan
IGC Pharma Converts $1.15M Insider Debt Into Equity at $0.27 in Private Issuance - TradingView
IGCIGC Pharma Inc Revenue Breakdown - Finviz
IGC Pharma (NYSE: IGC) CEO and CFO Acquire More Than 4.2 Million Shares - marketscreener.com
Form 4 IGC Pharma Inc For: 1 July By Investing.com - Investing.com Nigeria
IGC Pharma (IGC) CEO converts $601K company debt into 2.23M shares - Stock Titan
Debt-for-equity swap gives IGC Pharma (IGC) PFO 2.0M new shares - Stock Titan
Stocks Under $1: TNMG, SRFM, PRSO, KNDI, IGC Offer Multibagger Potential as AI Boom Accelerates - openPR.com
MultiBagger MicroCaps IGC, RCT, PBK, HUMA, PRSO Stocks to Watch Now - openPR.com
IGC Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock UptickLow Estimate Range - dars.gov.et
Enterprise value to revenue forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView
IGC Pharma, Inc. Actuals & Estimates (AMEX:IGC) - TradingView
IGC Pharma, Inc. Actuals & Estimates (SWB:IGS1) - TradingView
Enterprise value to EBITDA forward of IGC Pharma, Inc. – AMEX:IGC - TradingView
Enterprise value to EBITDA forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView
IGC Pharma, Inc. Actuals & Estimates (DUS:IGS1) - TradingView
Enterprise value to EBIT forward of IGC Pharma, Inc. – AMEX:IGC - TradingView
IGC Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView
0.79%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):